About Conference

We are delighted to welcome you to the 17th World Conference on Gynecology, Obstetrics, and Women’s Health, taking place on August 21–22, 2025, in London, UK. This prestigious annual gathering brings together a diverse international community of clinicians, researchers, educators, public health professionals, and policymakers who are committed to improving the health and well-being of women across the globe.

The conference aims to foster interdisciplinary dialogue, promote evidence-based practices, and enhance collaborative efforts to address the evolving challenges in women’s reproductive health, maternal-fetal medicine, and preventive care. Attendees will benefit from high-quality keynote sessions, oral and poster presentations, interactive workshops, panel discussions, and networking opportunities that cater to a global audience of healthcare professionals and researchers.

Why Attend?

The conference provides an unmatched opportunity to gain insights from leaders in the field and to:

• Stay updated with the latest trends and evidence-based practices in gynecology, obstetrics, and women's health.
• Present your research and receive constructive feedback from peers and experts.
• Network with global professionals to exchange ideas, form collaborations, and explore career opportunities.
• Participate in skill-building workshops and interactive sessions that enhance clinical and research capabilities.
• Discover new technologies, tools, and solutions from industry partners through exhibitions and product demos.

Target Audience

• Gynecologists
• Obstetricians
• Reproductive Endocrinologists
• Maternal-Fetal Medicine Specialists
• Women’s Health Nurse Practitioners
• Primary Care Physicians
• Urogynecologists
• Gynecologic Oncologists
• Family Planning Specialists
• Clinical Researchers in Women’s Health
• Medical and Health Science Professors
• Postgraduate and PhD Students
• Public Health Professionals
• Policy Makers in Women’s Health
• Non-Governmental Organizations (NGOs) working in maternal health
• Mental Health Professionals focusing on women's issues
• Pharmaceutical and Medical Device Companies
• Fertility Clinic Experts and Technicians

Sessions and Tracks

Track 01:  Maternal Health & Safe Pregnancy

Maternal health is a fundamental aspect of public health, influencing both maternal and neonatal outcomes. Despite significant medical advances, complications during pregnancy and childbirth remain leading causes of maternal mortality worldwide. Preventable conditions like hemorrhage, infections, and hypertensive disorders contribute to these deaths, particularly in low- and middle-income countries. Early and continuous antenatal care plays a crucial role in reducing maternal risks. Timely screening for conditions such as gestational diabetes, anemia, and preeclampsia allows for early intervention and better management of pregnancy-related complications. Regular check-ups also provide opportunities for preventive measures, such as vaccinations, nutritional advice, and the administration of essential supplements. Labor and delivery are critical periods for maternal health. Skilled birth attendants, safe delivery environments, and emergency obstetric care are essential to handle potential complications. Postnatal care is just as important, focusing on the mother’s recovery and addressing any complications like infections or postpartum hemorrhage. Social factors, including access to healthcare, education, and gender equality, also impact maternal health.

Track 02:  Advances in Obstetrics

Obstetrics has witnessed remarkable progress over the years, significantly improving maternal and fetal health outcomes. With advancements in medical technology, clinical practices, and healthcare delivery, the field has made significant strides in reducing maternal mortality, enhancing prenatal care, and ensuring safer labor and delivery. Developments in obstetrics is the increased use of minimally invasive techniques, including laparoscopic and robotic surgeries. These methods have improved outcomes in procedures such as cesarean sections, myomectomies, and tubal ligations, resulting in shorter recovery times and reduced risks of complications. The management of high-risk pregnancies has also evolved, with better monitoring of conditions such as gestational diabetes, hypertension, and preeclampsia. The development of advanced monitoring technologies and the increased availability of maternal-fetal medicine specialists have helped ensure that pregnancies with higher risk factors are more closely managed, leading to improved outcomes for both mother and child. With these ongoing advancements, the field of obstetrics continues to improve maternal health, ensuring that more women experience safe pregnancies and deliveries, regardless of location or risk factors.

Track 03:  Reproductive Health & Fertility

Advances in reproductive health and fertility have revolutionized the ways in which individuals and couples manage their reproductive choices. Over recent decades, the field has seen tremendous progress in understanding and treating various reproductive health issues, enhancing both fertility and overall reproductive well-being. Improvements in fertility preservation have empowered individuals to make informed decisions about their reproductive futures. The ability to freeze eggs, sperm, and embryos has provided individuals, especially women, with greater flexibility in delaying parenthood without compromising their fertility potential. This development is particularly beneficial for those undergoing cancer treatments or those choosing to pursue careers and education before starting a family. Advances in diagnostic tools have enhanced the ability to detect and treat fertility-related issues. Non-invasive tests, hormonal profiling, and imaging techniques such as hysterosalpingography and laparoscopy have made it easier to identify conditions like polycystic ovary syndrome, endometriosis, and male infertility. Public health campaigns and educational programs have empowered individuals to make informed decisions about their reproductive health and well-being.

Track 04: Gynecologic Oncology

Gynecologic oncology is a specialized field of medicine that focuses on the diagnosis, treatment, and management of cancers affecting the female reproductive system. These cancers include those of the ovaries, uterus, cervix, vulva, and vagina. Gynecologic oncologists are trained to treat these cancers using a combination of surgery, chemotherapy, radiation therapy, and targeted therapies. Advancements in diagnostic techniques such as high-resolution ultrasounds, Pap smears, and genetic testing enable early identification of gynecologic cancers. Early detection significantly increases the chances of successful treatment and better survival rates. Personalized therapies, including targeted therapies and immunotherapy, improve the effectiveness of treatments and reduce unnecessary side effects.  While minimally invasive techniques reduce many risks, any surgery carries potential complications, such as infection, bleeding, or injury to surrounding organs. Major surgeries, including hysterectomies and oophorectomies, can also have long-term effects, including changes in hormone levels and fertility. Chemotherapy, often used in the treatment of gynecologic cancers, can cause several side effects due to its impact on both cancerous and healthy cells.

Track 05: Minimally Invasive Gynecologic Surgery

Minimally invasive gynecologic surgery refers to surgical procedures used to treat conditions affecting the female reproductive organs that are performed with small incisions or no incisions at all. These surgeries typically use specialized tools, including laparoscopy and robotic-assisted te chniques. They are commonly employed to treat conditions such as fibroids, ovarian cysts, endometriosis, pelvic organ prolapse, and cancers of the reproductive organs. Minimally invasive procedures are preferred for their ability to achieve the desired surgical outcomes while reducing trauma to the body compared to traditional open surgery. Minimally invasive gynecologic surgery offers significant benefits, including faster recovery, reduced risk of complications, and better cosmetic outcomes. While the adverse effects and side effects are generally minimal, they are still a consideration, and patients should work closely with their healthcare team to understand potential risks and make informed decisions. With advancements in surgical technology, these procedures continue to evolve, improving the quality of care for women undergoing gynecologic surgeries.

Track 06: High-Risk Pregnancy Management

High-risk pregnancy refers to a pregnancy in which there are increased chances of complications that may affect the mother, the fetus, or both. Various factors contribute to a pregnancy being classified as high-risk, including maternal age, pre-existing medical conditions. complications during previous pregnancies, multiple pregnancies, or any issues that develop during the current pregnancy (e.g., gestational diabetes, preeclampsia). Managing high-risk pregnancies requires specialized care to monitor and address potential complications to ensure the best outcomes for both mother and baby. High-risk pregnancies often require a more personalized approach to care. For women with pre-existing medical conditions, such as diabetes or hypertension, high-risk pregnancy management focuses on minimize the risk of complications. Management of high-risk pregnancies includes carefully planning for labor and delivery. If complications such as preeclampsia or gestational diabetes are present, healthcare providers may recommend early induction or a cesarean section to avoid risks to the mother or baby.

Track 07: Polycystic Ovary Syndrome

Polycystic Ovary Syndrome is a common hormonal disorder affecting women of reproductive age. It is characterized by irregular menstrual cycles, elevated levels of androgens (male hormones), and the presence of multiple small cysts on the ovaries. PCOS is also associated with metabolic issues such as insulin resistance, obesity, and an increased risk of type 2 diabetes and cardiovascular disease. Treatment and lifestyle changes can help normalize hormonal levels, leading to more regular periods and improved fertility. Managing PCOS can reduce symptoms such as acne, excessive hair growth, and scalp hair thinning by lowering androgen levels. Healthy diet, exercise, and sometimes medication improve insulin sensitivity, aid in weight loss, and lower the risk of type 2 diabetes and heart disease. Improved hormonal balance often leads to clearer skin and reduced mood swings or anxiety, improving quality of life.

Track 08:  Urogynecology & Pelvic Floor Disorders

Urogynecology is a specialized field of gynecology and urology that focuses on the diagnosis and treatment of pelvic floor disorders in women. These disorders involve weakness or dysfunction of the pelvic floor muscles and connective tissues, which support the bladder, uterus, vagina, and rectum. These conditions can result from childbirth, aging, menopause, obesity, surgery, or heavy physical labor and significantly affect a woman’s quality of life. Urogynecologists use both non-surgical and surgical methods to manage these conditions, including physical therapy, medication, pessary devices, and minimally invasive surgeries. Urogynecology continues to evolve with ongoing research into regenerative medicine, novel biomaterials, and patient-centered care models, making it a dynamic and impactful area of women’s health. Initial treatments are often non-invasive, such as pelvic floor physical therapy, biofeedback, behavioral modifications, and lifestyle changes. Pessary devices removable supports inserted into the vagina are also commonly used to manage pelvic organ prolapse non-surgically.

Track 09: Menopause, Aging & Hormonal Health

Menopause marks a significant transition in a woman’s life, typically occurring between the ages of 45 and 55. It is characterized by the natural decline in reproductive hormones, particularly estrogen and progesterone, resulting in the permanent cessation of menstruation. While menopause is a normal biological milestone, the accompanying physiological changes can vary widely in severity and duration. Common symptoms include hot flashes, night sweats, mood fluctuations, irritability, sleep disturbances, decreased libido, and vaginal dryness. These symptoms can significantly affect a woman's physical comfort, emotional health, and daily functioning.Hormone Replacement Therapy remains one of the most effective treatments for managing moderate to severe menopausal symptoms. However, it is not suitable for everyone, and its use requires careful risk-benefit analysis based on personal and family medical history. Emerging research is also exploring the role of the gut microbiome, chronobiology, and genetics in shaping the menopausal experience.

Track 10: Adolescent & Pediatric Gynecology

Adolescent and pediatric gynecology addresses the unique reproductive health concerns of girls and young women from infancy through the teenage years. This field encompasses the diagnosis and treatment of issues such as congenital anomalies, early or delayed puberty, menstrual irregularities, and disorders like polycystic ovary syndrome in adolescence. It also involves education about sexual and reproductive health, consent, and the prevention of sexually transmitted infections. A key component of care is ensuring privacy, sensitivity, and age-appropriate communication to foster trust and understanding. Addressing gynecologic issues early helps prevent complications later in life and lays the foundation for a healthy reproductive future. It will explore best practices in managing adolescent menstrual disorders, providing contraception safely and effectively, and supporting those dealing with complex conditions such as polycystic ovary syndrome or gender dysphoria. Special attention will be given to trauma-informed care for young patients, especially in cases involving sexual abuse or emotional trauma. By integrating clinical care with education and emotional support, aims to promote lifelong reproductive health and wellness from the earliest stages of development.

Track 11: Maternal Mental Health & Emotional Well-being

Mental health disorders are among the most common yet least addressed complications of pregnancy and childbirth, impacting up to one in five women globally. Conditions such as prenatal and postpartum depression, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, and postpartum psychosis not only affect the mother's emotional and psychological well-being but also have lasting consequences on infant development, bonding, breastfeeding, and overall family dynamics. Despite their prevalence, maternal mental health concerns often go undetected due to stigma, lack of awareness, and insufficient integration of mental health services into routine obstetric care. Early identification, regular mental health screening during antenatal and postnatal visits, and timely interventions are crucial to reducing the burden of these conditions. Screening tools such as the Edinburgh Postnatal Depression Scale and Patient Health Questionnaire  can be effectively implemented in primary and maternity care settings. The goal is to foster a healthcare culture that recognizes emotional well-being as essential to safe pregnancy and motherhood, ensuring every woman receives the compassionate, competent care she deserves before, during, and after childbirth.

Track 12: Reproductive Rights & Policy

Sexual and reproductive health and rights are fundamental components of women's health, bodily autonomy, and gender equality. Access to comprehensive reproductive services including contraception, safe abortion, fertility treatments, sexually transmitted infection  prevention, and maternal care is not only a medical concern but also a critical public health and human rights issue. Global disparities in SRHR access remain stark, particularly in low- and middle-income countries and marginalized populations, where restrictive laws, stigma, poverty, and lack of education limit a woman’s ability to make informed choices about her reproductive health. In many parts of the world, women and girls face significant barriers to obtaining necessary reproductive healthcare, which can have devastating consequences on their health, well-being, and economic empowerment Lack of access to sexual and reproductive health education exacerbates the issue, leaving individuals without the knowledge required to make informed choices about their bodies, relationships, and reproductive futures. The right to safe, legal, and affordable abortion remains a contentious issue globally, with many women unable to access necessary services due to legal restrictions, lack of healthcare infrastructure, and societal stigma. As a result, women are often forced to seek unsafe, illegal abortions, putting their health and lives at risk.


Track 13: Breast Health & Disorders

Breast health is a vital component of women’s overall well-being, encompassing both benign and malignant conditions that require ongoing awareness, early detection, and multidisciplinary management. As breast cancer continues to be the most commonly diagnosed cancer among women worldwide, with increasing incidence even in younger populations, early intervention strategies are more critical than ever. Gynecology 2025 will focus on the comprehensive care of breast-related disorders, including screening guidelines, risk assessment, genetic counseling, imaging advancements, and innovations in treatment. It will also explore the evaluation and management of benign breast conditions such as fibroadenomas, cysts, mastitis, and hormonal breast pain, which are often a source of anxiety and require careful clinical judgment. The integration of breast health into routine gynecological care is essential, especially as gynecologists often serve as the first point of contact for women experiencing breast symptoms. Emphasis will be placed on patient education regarding self-examination, lifestyle risk factors, and the importance of adherence to mammography and ultrasound screening schedules. Advances in diagnostics such as digital breast tomosynthesis, MRI  and AI-assisted imaging are improving early detection, particularly in dense breast tissue, and will be key topics of discussion.

Track 14: Endometriosis & Chronic Pelvic Pain

Endometriosis is a complex, chronic gynecologic condition characterized by the presence of endometrial-like tissue outside the uterus, leading to inflammation, scarring, and a range of debilitating symptoms, most notably chronic pelvic pain and infertility. Despite affecting an estimated 10% of women of reproductive age, endometriosis remains underdiagnosed and often misunderstood, with many patients enduring years of symptoms before receiving a proper diagnosis. It emphasizes the need for earlier recognition, improved diagnostic tools, and more personalized, multidisciplinary treatment approaches for endometriosis and other chronic pelvic pain disorders.Treatment approaches have shifted toward individualized care that combines surgical management, hormonal therapy, pain relief strategies, fertility preservation, and lifestyle modifications. For many patients, a multidisciplinary team including gynecologists, pain specialists, physiotherapists, and mental health professionals is essential for comprehensive and sustainable care.

Track 15: Contraception & Family Planning

Contraception and family planning remain essential pillars of reproductive health, empowering individuals to make informed decisions about if, when, and how to have children. As contraceptive technologies evolve and access becomes more integrated into primary care, the landscape of family planning is shifting toward greater personalization and equity. In the context of Gynecology 2025, there is growing emphasis on the latest advancements in contraceptive options, innovations in delivery methods, patient-centered counseling, and strategies to address global disparities in access and education. Modern contraceptive methods, including long-acting reversible contraception such as intrauterine devices and implants, hormonal pills, patches, injectables, barrier methods, and emergency contraception, are being refined for greater effectiveness and user acceptability. Research into male contraception and non-hormonal alternatives is expanding the range of reproductive choices. Equally important is the provision of culturally sensitive, age-appropriate counseling that respects patient autonomy and reproductive intentions. Family planning services are also crucial for reducing maternal mortality, improving child health outcomes, and advancing gender equality. Integration of contraception into postpartum care, adolescent health programs, and chronic disease management is essential. Additional considerations include contraceptive options for medically complex cases, fertility preservation for cancer patients, and the ethical implications of informed consent and reproductive justice.

Track 16: Adolescent Gynecology

Adolescent gynecology addresses the unique reproductive health needs of girls and young women during a critical stage of physical, emotional, and social development. As puberty and menstruation begin, adolescents often face challenges related to menstrual irregularities, hormonal imbalances, acne, polycystic ovary syndrome , and concerns around body image and sexuality. Early education and access to adolescent-friendly healthcare services are essential for promoting healthy development and preventing long-term reproductive and mental health issues. This stage also presents an opportunity to introduce safe practices, HPV vaccination, menstrual hygiene management, and awareness of sexually transmitted infections. Providing care in a respectful, confidential, and nonjudgmental environment builds trust and encourages open communication about sensitive topics such as sexual orientation, contraception, consent, and emotional well-being. Clinicians must be trained to recognize signs of abuse, eating disorders, and mental health struggles that often present during adolescence. In line with the goals of Gynecology 2025, advocates for integrated, age-appropriate care that empowers adolescents to make informed, confident decisions about their health while laying the foundation for a lifetime of wellness.

Track 17: Vaginal Health & Infections

Vaginal health is a cornerstone of women's overall well-being, influencing both physical and emotional aspects of health. Common vaginal infections such as bacterial vaginosis, yeast infections, and sexually transmitted infections affect millions of women globally and can lead to significant discomfort, complications, and even long-term reproductive health issues if left untreated. Understanding the complex balance of the vaginal microbiome is essential for preventing these infections and maintaining overall vaginal health. Advances in diagnostics, including more sensitive tests for STIs and the role of probiotics in maintaining healthy vaginal flora, are contributing to improved care and outcomes. In addition to infections, other conditions such as vaginal atrophy, vulvodynia, and lichen sclerosus are important to address within this track. Hormonal changes, particularly during menopause, can lead to vaginal dryness and discomfort, highlighting the need for comprehensive care that includes not only medical treatment but also lifestyle interventions. Clinicians must also address the emotional and social impacts of vaginal health, providing support and education about prevention, self-care, and available treatments.

Track 18: Menstrual Disorders 

Menstrual disorders encompass a wide range of conditions that affect the regularity, flow, and severity of menstruation, and can significantly impact a woman’s quality of life. These disorders include conditions such as dysmenorrhea (painful periods), amenorrhea (absence of menstruation), menorrhagia (heavy menstrual bleeding), and irregular cycles, all of which may be indicative of underlying reproductive health issues such as polycystic ovary syndrome, endometriosis, fibroids, or thyroid disorders. The management of menstrual disorders has advanced significantly in recent years, with new treatment options, including hormonal therapies, intrauterine devices, and minimally invasive surgical techniques, offering relief and improving outcomes for many women. It is essential to approach menstrual disorders with a personalized, patient-centered strategy that considers the individual's symptoms, reproductive goals, and overall health. Beyond medical interventions, lifestyle modifications such as diet, exercise, and stress management play a crucial role in managing symptoms.Promoting awareness, reducing stigma, and empowering women to seek care for menstrual issues are vital steps in improving menstrual health worldwide.

Track 19: Endometriosis

Endometriosis is a chronic and often debilitating condition in which tissue similar to the lining of the uterus grows outside the uterine cavity, commonly affecting the ovaries, fallopian tubes, and the outer surface of the uterus. This tissue responds to hormonal fluctuations during the menstrual cycle, causing inflammation, pain, and the formation of scar tissue. Endometriosis can lead to severe pelvic pain, heavy menstrual bleeding, pain during intercourse, and infertility, affecting up to 10% of women worldwide. Unfortunately, the condition is often misdiagnosed or delayed due to a lack of awareness, leading to years of unnecessary suffering. The diagnosis of endometriosis typically involves laparoscopy, and while there is no cure, treatment options aim to manage symptoms and improve quality of life. These include pain management through non-steroidal anti-inflammatory drugs, hormonal therapies, and surgery. Advances in research are helping to uncover the genetic and molecular mechanisms underlying endometriosis, paving the way for more targeted and personalized treatments. There is an increasing focus on early diagnosis, reducing delays in treatment, and improving patient education about the condition. Comprehensive care models also consider the psychological impact of endometriosis, recognizing the need for mental health support in managing chronic pain and fertility concerns.

Track 20: Hormonal Imbalances

Hormonal imbalances are a common yet often underdiagnosed issue that can affect many aspects of a woman's health. The body’s endocrine system controls the release of hormones, which regulate everything from metabolism and mood to reproductive health and bone density. When there is an imbalance in hormones such as estrogen, progesterone, testosterone, and thyroid hormones, a range of symptoms can manifest, including irregular periods, weight gain or loss, fatigue, mood swings, and difficulty with conception. Conditions such as polycystic ovary syndrome, hyroid disorders, and premature ovarian insufficiency are frequently linked to hormonal imbalances. The increasing awareness of these disorders is crucial to improving early diagnosis and personalized treatment. Hormonal therapies, lifestyle adjustments, and dietary changes can help regulate hormonal levels, offering relief from symptoms and preventing long-term health consequences such as osteoporosis and cardiovascular disease. Advances in diagnostic tools, including hormone panels and imaging techniques, are enhancing the ability to accurately assess hormonal health, while new treatments aim to balance hormones in a more sustainable and effective way. As Gynecology 2025 progresses, addressing hormonal imbalances in a holistic and individualized manner will continue to be a key component of reproductive health care, ensuring that women receive the support they need for long-term health and well-being.

Market Analysis

Over the past five years (2020–2025), gynecology, obstetrics, and women’s health have undergone profound changes influenced by the global COVID-19 pandemic, technological innovation, and an expanding focus on health equity. The pandemic initially caused severe disruptions in maternal health services, with WHO reporting in 2021 that 70% of countries experienced delays or interruptions in essential reproductive care. Despite these challenges, the crisis accelerated the global adoption of telehealth; the American College of Obstetricians and Gynecologists noted a 400% surge in telemedicine use in 2020 alone. Femtech solutions gained momentum, with the market expanding from $22 billion in 2020 to over $60 billion by 2025 (Frost & Sullivan). Tools like AI-enabled fertility trackers, remote fetal monitoring devices, and virtual mental health platforms reached millions globally. Progress in maternal health also became evident: WHO data indicates a global drop in maternal mortality ratio (MMR) from 223 per 100,000 live births in 2020 to 191 by 2024 a 14.3% decline. Countries like India and Ethiopia saw even steeper reductions, up to 20%, due to improved midwifery training and emergency obstetric services. At the same time, concerning disparities emerged: the United States recorded a sharp rise in MMR, reaching 32.9 per 100,000 in 2021, disproportionately affecting Black and Indigenous women. Advances in assisted reproductive technology made headlines, with IVF success rates climbing to 47% for women under 35, and elective egg freezing becoming mainstream in developed nations. Moreover, rising awareness around conditions like endometriosis, polycystic ovarian syndrome, and uterine fibroids affecting up to 30% of reproductive-age women globally led to increased research funding, earlier diagnoses, and personalized treatment pathways. Gynecologic cancer screening also benefited from technology, particularly with HPV-based cervical cancer screening, which improved early detection and prevention efforts. Robotic-assisted laparoscopic surgery became a standard for hysterectomy and fibroid removal, increasing surgical precision and reducing recovery time. Amid these advancements, governments and NGOs strengthened initiatives around menstrual hygiene, family planning, gender-based violence prevention, and mental health support, recognizing that comprehensive women’s health extends beyond reproductive care.

Looking ahead, the next five years (2025–2030) are expected to usher in a new era of innovation, personalization, and inclusivity in gynecology and women’s health. Artificial intelligence and machine learning will increasingly enhance diagnostics, especially in detecting gynecologic cancers like cervical, ovarian, and endometrial, where early intervention is critical. According to MarketsandMarkets, AI use in women’s health diagnostics could surpass $1.1 billion by 2030. Precision medicine—tailoring treatment based on genetic, environmental, and lifestyle factors—will become routine in managing conditions such as PCOS, infertility, and hormone imbalances. Advances in in-vitro gametogenesis, gene editing, and lab-grown reproductive cells may dramatically alter fertility options for cancer survivors, LGBTQ+ individuals, and women delaying childbearing. Global efforts to reduce maternal mortality will continue, driven by the UN’s Sustainable Development Goal 3.1, which aims to bring MMR below 70 per 100,000 live births by 2030. Investment in community-based obstetric care, mobile ultrasound units, and low-cost postpartum hemorrhage management tools will expand in lower-income regions. Menstrual equity initiatives are gaining policy traction; by 2030, at least 80% of low-income nations are projected to implement national strategies for free or subsidized menstrual products in schools and workplaces. Post-pandemic shifts in mental health awareness will likely lead to universal screening for postpartum depression currently affecting 10–15% of mothers and integration of trauma-informed care models. Additionally, with aging populations in Europe, Japan, and the U.S., menopause care, osteoporosis prevention, and gynecologic oncology will become pressing priorities. Wearables and biosensors for hormonal tracking, bone density, and sleep cycles will become widely adopted in midlife women’s care. The 17th World Conference on Gynecology, Obstetrics and Women’s Health in London will serve as a vital platform for global experts, researchers, policymakers, and advocates to discuss these milestones, share best practices, and shape an inclusive, data-driven roadmap for the next chapter in women’s health.

Past Conference Report

The "16th World Conference on Gynecology Obstetrics and Women's Health" will take place from December  12– 13, 2024, in Rome, Italy and will feature prompt keynote talks, oral, poster presentations, and exhibitions. Gynecology Conferences cordially invites you to attend. "Innovations and Advancements in Gynecology and Obstetrics and Women health  is the conference's main theme. CME-CPD Credits are offered.

We organize 3000+ global events, including 700+ conferences, 1300+ symposiums, and 1300+ workshops on business, engineering, medicine, and other fields of science and technology.

Gyenecology 2024 attracts approximately 300 professionals in fertility, assisted conception, sexual health, and reproductive biology with its cutting edge programmer of renowned international speakers. The goal of this conference is to bring together individuals from all walks of life, including students, lecturers, assistant professors, professors, directors, chairman, chancellors, scientists, doctors, managing directors, managing directors, chief executive officers, and Nobel Laureates, and to provide them with a forum on which to exchange knowledge and discuss recent developments in the field of women's health. This year's agenda offers you the chance to take part in or organize a Workshop in addition to cutting-edge presentations and discussions.